Home › Funds › Pale Fire Capital SE › TARS

Pale Fire Capital SE position in TARS

TARSUS PHARMACEUTICALS INC · Health Care

Pale Fire Capital SE reported holding 9,802 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$617K, representing 0.04% of its reported portfolio and ranking #40 among its reported holdings. Pale Fire Capital SE has disclosed TARS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)9.80K sh
Reported value held$616.94K
Portfolio Weight0.04%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Pale Fire Capital SE's TARS position evolved

Pale Fire Capital SE first disclosed a stake in TARS in Q3 2025 at 7,075 shares (US$420K). The position peaked in Q2 2026 at 9,802 shares, worth US$617K. Across 4 filings, Pale Fire Capital SE increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,802 shares valued at US$617K — an increase of 4,150 shares quarter over quarter.. Notable position changes include a 65% trim in Q4 2025 (shares fell 14% over the following quarter), a 131% increase in Q1 2026 (shares fell 10% over the following quarter), a 73% increase in Q2 2026 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 7.08K $420.47K New
Q4 2025 2.45K $200.77K Reduce
Q1 2026 5.65K $396.49K Add
Q2 2026 9.80K $616.94K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARS and 13F data

TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$230.8M), RTW INVESTMENTS, LP (US$211.3M), Paradigm Biocapital Advisors LP (US$174.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARS

All TARS fund holders →

FAQ

How long has Pale Fire Capital SE held TARS?

Pale Fire Capital SE has disclosed TARS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Pale Fire Capital SE's current position in TARS?

As of Q2 2026, Pale Fire Capital SE holds 9.80K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $616.94K, representing 0.04% of its reported portfolio and ranking #40.

Has Pale Fire Capital SE been buying or selling TARS?

In the latest 13F filing (Q2 2026), Pale Fire Capital SE increased its position in TARS. The position peaked in Q2 2026 at 9.80K shares.

Which other funds hold TARS?

Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.